Clinical and Electrophysiological Patterns of Chronic Dysimmune Polyneuropathy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorAssiut University
About this trial
Chronic dysimmune neuropathies (CDN) are a heterogenous group of acquired inflammatory demyelinating neuropathies including chronic inflammatory demyelinating polyneuropathies (CIDP), Lewis-Sumner Syndrome (LSS), multifocal motor neuropathy (MMN) and other rare entities.
Despite their relatively low prevalence, CDN lead to substantial costs for patients and society. CDN are usually misdiagnosed due to progressive nature of the disease with little known data regarding disease activity and treatment response
Eligibility criteria
Qualifiers
Age > 18 years, both sexes, history of sensory and/or motor complaint with progressive course over more 2 months
Disqualifiers
*Patients with systemic diseases (DM, chronic kidney or liver disease, thyroid disease, vitamin B12 deficiency)
Family history of peripheral neuropathy or neurological symptoms suggestive for heredo-familial neurological disorders
Patients with infective cause as (HBV, HCV, HIV, leprosy)
Toxic and drug induced polyneuropathy (chemotherapeutics, antimicrobial ..
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov